June 9th, 2017- A Federal jury in Illinois found AbbVie Inc., an Abbot Laboratories spinoff, guilty of keeping information about their product Depakote from the doctors in charge of prescribing it. Christina Raquel’s doctors prescribed her with Depakote as a treatment for bipolar depression before... Read More

After a review of lawsuits across a number of districts, Florida’s federal court has chosen to consolidate all matters regarding Abilify. The companies responsible for its manufacture, Bristol-Myers Squibb and Otsuka Pharmaceuticals, allegedly failed to include proper warnings as to the drug’s side effects. Drug... Read More

The largest verdict in a Risperdal lawsuit has been awarded to a teenage boy who alleged the antipsychotic drug led to his growth of female-size breasts. Earlier this month, J&J was ordered to pay $70 million in compensatory damages to the Tennessee plaintiff. The jury in the Philadelphia case determined that... Read More

The findings of a new study may bolster allegations raised in Nexium lawsuits: that the heartburn drug can dramatically increase a person’s risk for kidney problems and failure. The research, published in the Journal of the American Society of Nephrology this month, found that patients... Read More

The chemotherapy drug Taxotere has been touted as a powerful cancer fighter for many years, helping those with some types of cancer find effective treatment for their illness. However, one of the potential side effects related to Taxotere, permanent hair loss, has not been widely... Read More

Hundreds of patients suffering from diabetes type 2 and their families have filed lawsuits over undisclosed heath risks associated with Onglyza (the brand name of the drug saxagliptin) and Kombiglyze XR. Most complaints have been filed over connections between Onglyza and heart failure, a link supported... Read More

Pharmaceutical company GlaxoSmithKline (GSK) will have to defend itself against racketeering charges in connection to its marketing of the diabetes drug Avandia according to a Third Circuit ruling. The three judge panel of the Third Circuit upheld U.S. District Judge Cynthia Rufe’s 2013 refusal to... Read More

New diabetes drugs that have been highly touted for their ability to manage even stubborn cases of type 2 diabetes now come with a warning from the FDA. The new class of drugs, which are manufactured by pharmaceutical giants Johnson & Johnson, Eli Lily and... Read More

In recent years, news of the dangers of some diabetes drugs has alarmed patients and the healthcare community. Many lawsuits have already been filed with regard to complications allegedly caused by Actos, Januvia, and Janumet. Now, patients taking Onglyza may have cause for concern. A... Read More

Three anonymous sources have disclosed to Bloomberg News that Takeda Pharmaceuticals has offered $2.2 billion in settlement funds to resolve pending Actos bladder cancer cases. If accepted, the offer would be one of the largest settlements in the history of U.S. drug or medical device... Read More